本页面由Tiger Trade Technology Pte. Ltd.提供服务

InflaRx N.V.

2.10
+0.08003.96%
盘前2.120.0179+0.85%08:28 EDT
成交量:41.99万
成交额:87.34万
市值:3.09亿
市盈率:-3.67
高:2.12
开:2.03
低:2.03
收:2.02
52周最高:2.95
52周最低:0.7984
股本:1.47亿
流通股本:9,811.47万
量比:0.51
换手率:0.43%
股息:- -
股息率:- -
每股收益(TTM):-0.5715
每股收益(LYR):-0.7963
净资产收益率:-38.52%
总资产收益率:-18.54%
市净率:1.81
市盈率(LYR):-2.64

数据加载中...

公司资料

公司名字:
InflaRx N.V.
交易所:
NASDAQ
成立时间:
2007
员工人数:
65
公司地址:
Winzerlaer Str. 2,Jena,Thuringia,Germany
邮编:
07745
传真:
- -
简介:
InflaRx N.V.于2017年6月根据荷兰法律成立,根据公司重组的条款,该公司是一家InflaRx GmbH的控股的公司。该公司是一家临床阶段的生物制药公司,专注于应用其独有的反C5a技术来发现和开发一种名为C5a的补充激活因子的一级、有效和特异性抑制剂。C5a是一种强大的炎症介质,涉及多种自身免疫和其他炎症疾病的进展。

董事

名称
职位
Nicolas Fulpius
Chairman of the Board and Non-Executive Director
Niels Riedemann
Chief Executive Officer and Executive Director
Anthony Gibney
Non-Executive Director
Hege Hellstrom
Non-Executive Director
Mark Kuebler
Non-Executive Director
Renfeng Guo
Chief Scientific Officer and Executive Director
Richard Brudnick
Non-Executive Director

股东

名称
职位
Niels Riedemann
Chief Executive Officer and Executive Director
Derval O Carroll
Global Head of Regulatory Affairs and Compliance and Senior Vice President
Thomas Taapken
Chief Financial Officer
Camilla Chong
Chief Medical Officer
Renfeng Guo
Chief Scientific Officer and Executive Director